Department of visceral and transplant surgery, Bern University Hospital
Bern, 3010, Switzerland
NCT Number: NCT00681499
Patients with malignant diseases are increasingly receiving more extensive hepatic resections, with im-proved preoperative and postoperative care leading to a reduced postoperative morbidity and mortality. In this setting, postoperative quality of life may become as important as overall patient survival. In this study we will be investigating the effect of the initial disease for which hepatic resection was carried out on short- and long-term quality of life.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Bern, 3010, Switzerland
Background: Due to advances in operative methods and perioperative care, mortality and morbidity following major hepatic resection have decreased substantially, making long-term quality of life (QoL) an increasingly prominent issue.
Objectives: We plan on evaluating whether postoperative diagnosis is associated with long-term QoL and health in patients who require hepatic surgery for benign or malignant diseases and how QoL evolves with time.
Method: QoL will be evaluated using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-30 and the liver-specific QLQ-LMC21 module. All patients requiring hepatic surgery aged >18 years will be included in the study. QoL evaluation is carried out preoperatively and at set intervals postoperatively.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: preoperatively, 1-,3-,6-,12 months postoperatively
University of Bern
Other
Long-term Evaluation of the Quality of Life After Major Hepatic Resection for Malignant and Benign Diseases.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04618692
Digestive System Diseases, Digestive System Neoplasms
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT04518852
Adenocarcinoma, Antineoplastic Agents
Chengdu, Sichuan, China
View Trial DetailsNCT03405909
Adenocarcinoma, Carcinoma
Erlangen, Bavaria, Germany
View Trial DetailsNCT01394497
Adenocarcinoma, Carcinoma
Padova, Italy
View Trial Details